Detalhe da pesquisa
1.
Genomic aberrations and survival of patients with light-chain-only multiple myeloma undergoing autologous stem cell transplantation.
Biol Blood Marrow Transplant
; 17(12): 1790-5, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21658460
2.
Dutcher bodies in multiple myeloma are highly associated with translocation t(4;14) and IgA isotype.
Br J Haematol
; 171(5): 890-2, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25907777
3.
CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma.
Haematologica
; 95(9): 1542-7, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20421271
4.
Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
Clin Lymphoma Myeloma
; 9(1): 36-8, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19362968
5.
Cyclin kinase subunit 1B nuclear expression predicts an adverse outcome for patients with relapsed/refractory multiple myeloma treated with bortezomib.
Hum Pathol
; 43(6): 858-64, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22047644
6.
Analysis of chromosome 12p deletion in plasma cell dyscrasias.
Leuk Res
; 36(1): 32-6, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21982640
7.
p53 nuclear expression correlates with hemizygous TP53 deletion and predicts an adverse outcome for patients with relapsed/refractory multiple myeloma treated with lenalidomide.
Am J Clin Pathol
; 137(2): 208-12, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22261445
8.
Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia.
Am J Clin Pathol
; 133(1): 70-4, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20023260
9.
Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
Leuk Lymphoma
; 51(11): 2084-91, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20929319
10.
Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Am J Clin Pathol
; 133(1): 34-40, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20023256
11.
Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma.
Br J Haematol
; 138(3): 324-9, 2007 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17555471
12.
p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation.
Blood
; 105(1): 358-60, 2005 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15339849